{"id":"W3158447700","doi":"10.1016/j.cgh.2021.03.037","title":"Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies","year":2021,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Samsung; Norgine; Dr. Falk Pharma; Tillotts Pharma; Otsuka Pharmaceutical; Ferring Pharmaceuticals; Herlev Hospital; Sheffield Teaching Hospitals NHS Foundation Trust; AbbVie; University of Alberta; Mylan; Merck; Tel Aviv University; Meso Scale Diagnostics; Teva Pharmaceutical Industries; Celgene; Pfizer; Biogen; Janssen Pharmaceuticals; Ablynx; Gilead Sciences; Celltrion; Roche; Genentech; Hospira; Amgen; Vifor Pharma; Erasmus Universitair Medisch Centrum Rotterdam; Shire; Allergan; AstraZeneca; Eli Lilly and Company; Takeda Pharmaceutical Company","keywords":"Medicine; Meta-analysis; Disease; Internal medicine; Crohn's disease; Oncology; Tumor necrosis factor alpha; Tumor necrosis factor α","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03668576,0.002930302,0.01122722,0.003500615,0.0006180495,0.002711108,0.00214449,0.002056919,0.002156954],"category_scores_gemma":[0.04030921,0.001537367,0.05187825,0.004431314,0.0006384815,0.001352041,0.00177665,0.002252787,0.0003190907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001012568,"about_ca_system_score_gemma":0.001264964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00401013,"about_ca_topic_score_gemma":0.004906756,"domain_scores_codex":[0.9775539,0.0153584,0.0029924,0.00256713,0.001152638,0.0003755804],"domain_scores_gemma":[0.9600626,0.0318292,0.003657139,0.002786241,0.001309425,0.0003554903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005003525,0.0000210253,0.02909602,0.01197647,0.9477559,0.0001211131,0.00003900554,0.001596227,0.0002196131,0.00006923594,0.0002959067,0.003805993],"study_design_scores_gemma":[0.0009295979,0.0003063822,0.01082708,0.0008687356,0.9847822,0.0001190508,0.00002287507,0.001055938,0.0001482341,0.0002242697,0.0006942905,0.00002136022],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.218799,0.7548857,0.01435795,0.0008995583,0.0006213331,0.0009128302,0.007928327,0.0003204391,0.001274922],"genre_scores_gemma":[0.9454536,0.04290215,0.005342316,0.0006234728,0.0001554131,0.0009775383,0.004015585,0.0001066084,0.00042327],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03668576,"threshold_uncertainty_score":0.1940152,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2982527033487506,"score_gpt":0.4156918865629277,"score_spread":0.117439183214177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}